Quarterly Results : Biocon
Bhagyashree Vivarekar / 25 Jan 2017
The company reported PAT of Rs. 171.3 crore, which represents a sequential QoQ increase of 16.77 per cent and a YoY increase of 64.55 per cent.
Biocon Ltd. reported its results for the quarter ended December 31, 2016 yesterday.
The total sales for Q3FY17 came in at Rs 1044.4 crore, which represents a 9.46 per cent sequential increase and 29.4 per cent YoY increase.
The operating profit (EBIT) for the quarter amounted to Rs 205.8 crore and the EBIT margin stood at 19.71 per cent.
The company reported PAT of Rs. 171.3 crore, which represents a sequential QoQ increase of 16.77 per cent and a YoY increase of 64.55 per cent.
Biocon Limited is a fully integrated global healthcare company that delivers bio-pharmaceutical solutions. The company offers a range of products from fermentation derived small molecules to recombinant proteins and antibodies. The company also offers custom bio- manufacturing services to domestic and international pharmaceutical companies.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.